Ali Wang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Ubiquitin and proteasome pathways 2
-
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 1
- Co-authors
- Xiang Gu (4 shared papers)Xiaojun Chen (2 shared papers)Xiaojun Chen (1 shared paper)Xiang Gu (1 shared paper)Yue Xie (1 shared paper)Pengfei Li (1 shared paper)Ping Li (1 shared paper)Tao Wang (2 shared papers)
In The Last Decade
Ali Wang
7 papers receiving 90 citations
Peers
Comparison fields: 5 of 25
- Cancer Research 48
- Oncology 27
- Immunology 20
- Molecular Biology 55
- Pulmonary and Respiratory Medicine 19
Countries citing papers authored by Ali Wang
This map shows the geographic impact of Ali Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Wang more than expected).
Fields of papers citing papers by Ali Wang
This network shows the impact of papers produced by Ali Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Wang. The network helps show where Ali Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 31 | |
| 2 | 2020 | 24 | |
| 3 | 2022 | 17 | |
| 4 | 2019 | 15 | |
| 5 | 2020 | 2 | |
| 6 | 2025 | 1 | |
| 7 | 2018 | 1 |
About Ali Wang
Ali Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 7 papers that have together received 91 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers), Ubiquitin and proteasome pathways (2 papers), interferon and immune responses (1 paper), MicroRNA in disease regulation (1 paper), Nanoplatforms for cancer theranostics (1 paper), Prostate Cancer Treatment and Research (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Cancer Research (48 citations), Oncology (27 citations), Immunology (20 citations), Molecular Biology (55 citations) and Pulmonary and Respiratory Medicine (19 citations). Ali Wang has collaborated with scholars based in China and Germany. Frequent co-authors include Xiang Gu, Xiaojun Chen, Xiaojun Chen, Xiang Gu, Yue Xie, Pengfei Li, Ping Li, Pengfei Li, Tao Wang and Ping Li. Their work appears in journals such as Cancer Medicine, Disease Markers, Archives of Biochemistry and Biophysics, Cell Proliferation and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.